About
Male
Drew Fromkin is the Chief Executive Officer Proteovant, Vant Portfolio Operating Partner (Roivant Sciences) at Roivant Sciences.He attended Brandeis University.
Experience
- Chief Executive Officer Proteovant, Vant Portfolio Operating Partner (Roivant Sciences) · Roivant Sciences2021 – present
- Chairman · Tarveda Therapeutics2015 – present
- President and CEO · Clinical Data
- Chief Executive Officer · Proteovant Therapeutics
People at OrbiMed
Data from: crunchbase
